Photo, left to right: Svein Olaf Olsen and Astri Arnesen at the CHDI Therapeutics Conference in 2016.
The 15th Annual Huntington’s Disease (HD) Therapeutics Conference was taking place in Palm Springs. Over four days, from February 24 to 27, drug development was discussed.
The CHDI (Cure Huntington’s Disease Initiative) Foundation conference is a forum for drug discovery and development that cover all aspects of drug discovery related to Huntington’s disease (HD).
Sessions included: Huntington’s disease genotype and phenotype, somatic instability, path to prevention and Huntingtin lowering (exploring distribution, timing, safety and translation to the clinic).
Astri Arnesen, President the European Huntington Association, was present together with board member and husband Svein Olaf Olsen. During the conference they asked some of the attendees what their take-home messages to you were.
Here are their messages: